As you are most likely aware, April marks the yearly observation of STD Awareness Month. To honor the month, NCSD is planning a number of activities to bring attention to the importance of STD prevention, testing, and treatment. Beginning next week, we will be hosting a STD Awareness Blog series on RH Reality Check. Similar to last year’s series,these blogs will cover a variety of topics and will be written by both NCSD staff and coalition partners. Please keep checking back for updates to the blog series!
To help you bring attention to STD Awareness Month in your area, we have composed a sample op-ed for use in your state, city, or territory, which is attached. This op-ed focuses on the continued urgency to prevent and decrease STDs, focusing on rising gonococcal resistance to antimicrobials and well as the connection between HIV and other STDs. This piece was not written to necessitate publication on April 1, but can be used throughout the month.
Please feel free to utilize the piece and submit it to a newspaper in your state. You will find that paragraph four calls on members to insert area-specific data. Making that section applicable to your state will increase the likelihood the op-ed will get printed. Feel free to edit the piece as needed and to reach out to us for assistance.
In addition, we have written an STD Awareness Month Resolution for your use, which is also attached. This resolution recognizes the month of April 2012 as “STD Awareness Month” and can be an important education tool to highlight the prevalence of STDs and the importance of testing and treatment.
In addition, as was sent out in a previous NCSD Weekly Update, in preparation for April's STD Awareness Month activities, CDC has refreshed the STD Awareness Resource Site. This web site was created for STD prevention partners and stakeholders to support STD prevention outreach.
On December 19th, 2013, the American Sexual Health Association (ASHA) and the National Coalition of STD Directors (NCSD) convened a small group of stakeholders from the policy, research, cancer, healthcare provider and sexual health fields to discuss potential policy actions to facilitate HPV/Pap co-testing, and adherence to screening guidelines.